AZboneage
Automated bone age calculation for pediatric patients using Greulich & Pyle methodology
Software · Cloud SaaSCompany source
Company profile
About AZmed SAS
AZmed SAS is a leading artificial intelligence company specializing in medical imaging and radiology solutions. The company's flagship product, the Rayvolve® AI Suite, leverages advanced AI algorithms and machine learning to rapidly interpret X-ray imaging data within real-world clinical practice. The platform enables early detection of pathology, reduces false positive rates, and guides more precise treatment plans. AZmed's mission is to help any doctor analyze any medical image, anywhere in the world. The company's product portfolio includes AZtrauma for fracture detection, AZchest for cardiac and lung abnormalities, AZmeasure for automated osteo-articular geometry characterization, and AZboneage for pediatric bone age calculation. These solutions are rigorously validated by leading institutions and have been deployed in over 2,500 healthcare centers across more than 55 countries. The platform integrates seamlessly with existing PACS systems and has analyzed over 15 million X-rays. AZmed's technology has demonstrated significant clinical impact, including 83% turnaround time reduction, 67% reduction in false negatives, and 36% reduction in reading time. The company is expanding into CT imaging with its new AZnod solution for lung nodule detection. AZmed maintains regulatory compliance with CE marking, FDA clearance, GDPR, and HIPAA standards, ensuring trust and reliability in acute clinical situations.
Company description AZmed SAS official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at AZmed SAS?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiomegaly
- Consolidation
- Dislocations
- FAI
- Flat/hollow foot
- Fractures
- Hallux valgus
- Hip dysplasia
- Joint effusions
- Leg length discrepancies
- Lung nodules
- Pediatric bone age assessment
- Pleural effusion
- Pneumothorax
- Pulmonary edema
- Rib fracture
- Scoliosis
Who it serves
- Emergency Departments
- Health Systems
- Hospitals
- Radiology Centers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: PACS.
Geographic context
MarketsEurope · Global - 55+ countries · North America · Romania mentioned specifically
Company sourceOfficial website
Company milestones
Platform expansion
December 2025: AZnod receives CE Marking for lung nodule detection on CT, marking company's entry into CT imaging. Over 15.3 million X-rays analyzed. Deployment in 2,500+ healthcare centers across 55+ countries.
Partnerships
Recorded partners
- Multiple pediatric hospitals including first in Romania
- MVZ Radiologie Karlsruhe
- University Hospitals (UH)
- Wrightington Hospital
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
AZchest
AI solution for detecting cardiac and lung abnormalities on chest X-rays
Software · Cloud SaaSCompany source
AZmeasure
Automated characterization of osteo-articular geometries including lengths and angles
Software · Cloud SaaSCompany source
AZnod
AI solution for lung nodule detection on CT scans
Software · Cloud SaaSCompany source
AZtrauma
AI radiology solution for detecting fractures, dislocations, and joint effusions on X-rays
Software · Cloud SaaSCompany source
Rayvolve AI Suite
Comprehensive AI-driven radiology platform for medical imaging analysis
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Rayvolve LNK243831 · 510k · Mar 26, 2025
Rayvolve PTX-PEK243808 · 510k · Mar 21, 2025
RayvolveK240845 · 510k · Jul 17, 2024
RayvolveK220164 · 510k · Jun 2, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
83% Turnaround Time reduction
AZtrauma fracture detection
67% False Negatives reduction
AZtrauma fracture detection
99.7% Negative predictive value
AZtrauma
36% Reading Time reduction
AZchest
11.4% Sensitivity improvement
AZchest
97.9% Negative predictive value
AZchest
1.4° Average MAE for Angles
AZmeasure
1.3mm Average MAE for Lengths
AZmeasure
AUC 0.913-0.9582
AZchest per abnormality
Readers AUC increased from 0.84 to 0.89
Overall diagnostic accuracy improvement
First pediatric hospital in Romania
Implementation of artificial intelligence in radiology for pediatric care
First pediatric hospital in Romania to implement AI in radiology
MVZ Radiologie Karlsruhe
Detection of fractures and thoracic pathologies with seamless PACS integration
Radiologists significantly speed up overall reporting while simultaneously increasing accuracy
University Hospitals (UH)
Fracture detection with high stand-alone accuracy to decrease medical errors and healthcare costs
High stand-alone accuracy, aided diagnostic accuracy, and decreased interpretation time
Wrightington Hospital
Fracture detection support for junior clinicians and emergency department practitioners, especially out of hours
More efficient and streamlined patient treatment pathway into Orthopaedic fracture clinic
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from AZmed SAS
Recent articles published on AZmed SAS's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.